Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: indirect (44), roundabout (6)

STH816 v1 Department of infection user handbook

Description: Microbiology and Specialist Virology Services User Handbook STH816/02-25 Issued Date 23.07.2025 Authorised by R. Allen Page 1 of 48 Con
Url: /Media/UHS-website-2019/Docs/Services/Pathology/STH816-v1-Department-of-infection-user-handbook.pdf

Having a tunnelled cuffed central venous catheter (TCVC) for parenteral support - patient information

Description: This factsheet explains what you need to know about having a tunnelled cuffed central venous catheter (TCVC) for parenteral support.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Having-a-tunnelled-cuffed-central-venous-catheter-TCVC-for-parenteral-support-3901-PIL.pdf

Whipple's procedure - patient information

Description: Your doctors have recommended that you have an operation called the Whipple's procedure. This is a complex operation to remove part
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Whipples-procedure-3311-PIL.pdf

Car parking diversion 9 to 11 May 2025

Description: Exit from bottom car park will be via normal exits Marshall will be in place to direct/stop traffic against vehicles
Url: /Media/UHS-website-2019/Docs/News/Car-parking-diversion-9-to-11-May-2025.pdf

Quality Committee ToR March 2025

Description: Quality Committee Terms of Reference Date Issued: 11 March 2025 Review Date: January 2026 Document Type: Terms of Reference Versio
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Quality-Committee-ToR-March-2025.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indication • Daratumumab in combination with lenal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

Epcoritamab -Cycle 2 (Onwards)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB – Cycle 2 Onwards - (28 day) Regimen • Lymphoma-Epcoritamab – Cycle 2 Onwards - (28 day) Indication • Treatment of adult patients wi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-2-Onwards-Ver1.pdf

Epcoritamab -Cycle 1 (Priming)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (28 day -Priming) Indication • Treatment of adult patients wi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

Masters in Medical Technology Innovation and Design - Clinical Director

Description: MTID Clinical Director – EOI Dear colleagues, The School of Healthcare Enterprise and Innovation in the
Url: /Media/Southampton-Clinical-Research/Downloads/Masters-in-Medical-Technology-Innovation-and-Design-Clinical-Director.pdf

People and OD Committee ToR September 2024

Description: People and Organisational Development Committee Terms of Reference Date Issued: 10 September 2024 Review Date: August 2025 Documen
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/People-and-OD-Committee-ToR-September-2024.pdf

251 to 260 of 293

Previous … 24 25 26 27 28 … Next